Weight matters: exploring the relationship between BMI status and glycemic control in diabetic patients

Israt Zerin Eva; Farhana Afrooz; Nazmul Kabir Qureshi; Chandina Ferdous

doi:10.18203/2320-6012.ijrms20243693

Authors

Israt Zerin Eva Department of Medicine, Uttara Adhunik Medical College and Hospital, Dhaka, Bangladesh
Farhana Afrooz Department of Endocrinology, Dr. Sirajul Islam Medical College and Hospital, Dhaka, Bangladesh
Nazmul Kabir Qureshi Department of Endocrinology & Medicine, National Healthcare Network, Uttara, Dhaka, Bangladesh
Chandina Ferdous Department of Endocrinology, National Healthcare Network, Uttara, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20243693

Keywords:

BMI, Glycemic Control, HbA1C

Abstract

Background: In the management of diabetes mellitus, understanding the interplay between body weight and glycemic control is crucial. The relationship between BMI status and glycemic control among diabetic patients is multifaceted and pivotal for optimizing treatment strategies and reducing complications. This study aims to assess the relationship between BMI status and glycemic control in diabetic patients.

Methods: This study was a cross-sectional design to assess the relationship between BMI status and glycemic control in diabetic patients conducted from November 2022 to October 2023 at National Healthcare Network (NHN), Uttara, Dhaka, Bangladesh. Data were collected from patient medical records and structured interviews, focusing on the fasting blood glucose (FBG) levels, HbA1C%, and body mass index (BMI). Pearson correlation coefficients were calculated to assess the strength of linear relationships between BMI, HbA1C, and glycemic control measures, with statistical significance set at p<0.05.

Results: In the study, for BMI 18-24, 60% had normal fasting blood glucose, while 67.9% had elevated levels; 64.0% had HbA1C <7%, and 67.6% had ≥7%. In BMI 25-30, 30% had normal fasting blood glucose, 16.7% had elevated levels, 25% had HbA1C <7%, and 18.7% had ≥7%. For BMI >30, 10% had normal fasting blood glucose, 15.4% had elevated levels, 12% had HbA1C <7%, and 13.7% had ≥7%.

Conclusions: A significant association was found between BMI status and glycemic control among diabetic patients. Higher BMI is correlated with poorer glycemic control, as indicated by elevated fasting blood sugar and HbA1C% levels. These findings emphasize the importance of weight management as a crucial component of diabetes care to achieve better glycemic control and reduce the risk of complications.

Metrics

Metrics Loading ...

References

International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.

Hu FB. Obesity and type 2 diabetes: epidemiology, risk factors, and pathogenesis. Diabetes Care. 2011;34(Suppl 2).

Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-6.

Sinclair AJ, Abdelhafiz AH, Rodríguez-Mañas L. Frailty and sarcopenia - newly emerging and high impact complications of diabetes. J Diabet Complicat. 2017;31(9):1465-73.

Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson AM, Gudbjörnsdóttir S, et al. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care. 2010;33(7):1640-6.

Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011;34(Suppl 2).

Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC, et al. Body-mass index and mortality among adults with incident type 2 diabetes. New Engl J Medi. 2014;370(3):233-44.

Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581-90.

Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308(23):2489-96.

Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet. 2018;391(10120):541-51.

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabet Res Clin Pract. 2018;138:271-81.

American Diabetes Association. Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1).

Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): a prospective observational study. BMJ. 2000;321(7258):405-12.

Gao M, Lv J. Associations between body mass index and impaired fasting glucose among adults in Northeast China. Diab, Metabol Syndr Obesity: Target Ther. 2021;14:1097-1105.

Cornell S, Halstenson C, Miller DK, editors. The Art and Science of Diabetes Care and Education. Association of Diabetes Care & Education Specialists; 2021.

Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circulat Res. 2016;118(11):1723-35.

Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL, et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. The Lancet. 2018;391(10138):2430-40.